PDE9A and autosomal recessive cerebellar ataxia: In addition, memory enhancements were noted, as evidenced by reduced latency and increased frequency in locating the platform in the Morris water maze test (Fig. 3F–I), indicating that Bay 73-6691 combats the clinical phenotype of ARCA by inhibiting PDE9A protein accumulation-mediated toxic effects.